Related Experiment Video

Updated: Jul 18, 2026

Coupled Assays for Monitoring Protein Refolding in Saccharomyces cerevisiae
13:52

Coupled Assays for Monitoring Protein Refolding in Saccharomyces cerevisiae

Published on: July 9, 2013

Heat shock protein 70 (HSP70) does not prevent the inhibition of cell growth in DU-145 cells treated with TGF-beta1

Y Ogawa1, Y Nakagami, R Ishizaki

  • 1Department of Urology, Showa University School of Medicine, Tokyo, Japan. ogawayos@med.showa-u.ac.jp

Anticancer Research
|February 19, 2002
PubMed
Abstract

Insights

Transforming growth factor-beta1 (TGF-beta1) inhibits prostate cancer cell growth and affects cell cycle progression. Heat shock protein 70 (HSP70) did not prevent TGF-beta1-induced growth inhibition in DU-145 cells.

Area of Science:

  • Cell biology
  • Cancer research
  • Molecular signaling

Background:

  • Mitogen-activated protein kinase (MAPK) pathways are involved in transforming growth factor-beta (TGF-beta) signaling.
  • Heat shock protein 70 (HSP70) can inhibit apoptosis by modulating MAPK signaling.
  • The interplay between TGF-beta and HSP70 signaling remains unclear.

Purpose of the Study:

  • To investigate the relationship between TGF-beta signaling and HSP70 in prostate cancer cells.
  • To determine the effect of TGF-beta1 on DU-145 cell proliferation, cell cycle, and MAPK activity.
  • To assess the role of HSP70 in mediating TGF-beta1's effects on cell growth.

Main Methods:

  • DU-145 prostate cancer cells were treated with varying concentrations of TGF-beta1.
  • Cell proliferation and cell cycle assays were conducted at multiple time points.
  • Western blotting was used to analyze the activity of HSP70 and specific MAPKs (JNK1, ERK1, ERK2, p38).

Main Results:

  • TGF-beta1 inhibited DU-145 cell growth and induced G1 phase cell cycle arrest in a dose-dependent manner.
  • HSP70 and JNK1 levels initially increased but then decreased post-treatment.
  • ERK1, ERK2, and p38 activities were reduced following TGF-beta1 exposure.

Conclusions:

  • HSP70 does not appear to protect DU-145 cells from TGF-beta1-induced growth inhibition.
  • TGF-beta1 modulates MAPK signaling pathways, including JNK, ERK, and p38, in prostate cancer cells.

More Related Videos

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells06:54

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells

Published on: October 27, 2020

Escherichia coli -Based Complementation Assay to Study the Chaperone Function of Heat Shock Protein 7007:14

Escherichia coli -Based Complementation Assay to Study the Chaperone Function of Heat Shock Protein 70

Published on: March 8, 2024

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...